AYTU BIOPHARMA, INC Additional Paid in Capital, Common Stock
AYTU BIOPHARMA, INC (AYTU) had Additional Paid in Capital, Common Stock of $344.42 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2023-11-14
- 2023-09-30: Additional Paid in Capital, Common Stock $344.42M.
- 2023-06-30: Additional Paid in Capital, Common Stock $343.49M.
- 2023-03-31: Additional Paid in Capital, Common Stock $342.58M.
- 2022-12-31: Additional Paid in Capital, Common Stock $340.29M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2023-09-30 | $344.42M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $343.49M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $342.58M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $340.29M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $336.13M 10-Q/A · filed 2023-02-21 | $345.25M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $331.39M 10-K · filed 2023-10-12 | $334.56M 10-K · filed 2022-09-27 |
| 2022-03-31 | $328.74M 10-Q · filed 2023-05-11 | $331.91M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $323.23M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $317.65M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $315.86M 10-K · filed 2022-09-27 | |
| 2017-06-30 | $73.07M 10-K · filed 2017-08-31 | |
| 2017-03-31 | $70.84M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $67.55M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $59.47M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $56.65M 10-K · filed 2017-08-31 | $56.65M 10-K · filed 2016-09-01 |
| 2016-03-31 | $48.83M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $39.25M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $39.06M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $39.00M 10-K · filed 2016-09-01 | $39.00M 10-K · filed 2015-09-28 |
| 2015-03-31 | $13.16M 10-Q · filed 2015-05-19 | |
| 2015-02-28 | $48.41K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $47.36K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $45.71K 10-Q · filed 2015-04-15 | |
| 2014-06-30 | $16.03M 10-K · filed 2015-09-28 | $12.41M 10-Q · filed 2015-05-19 |
| 2014-05-31 | $43.46K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $42.56K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $41.96K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $40.82K 10-K · filed 2014-11-26 | |
| 2013-05-31 | $40.13K 10-Q · filed 2013-06-28 | |
| 2013-02-28 | $38.04K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $36.99K 10-Q · filed 2013-01-14 | |
| 2012-08-31 | $34.64K 10-K · filed 2014-11-26 | |
| 2012-05-31 | $31.44K 10-Q · filed 2012-06-26 | |
| 2012-02-29 | $29.70K 10-Q · filed 2012-04-12 | |
| 2011-11-30 | $28.95K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | $27.30K 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |